Clinical Trials Browser

Phase 2 × Mouth Neoplasms × trametinib × Clear all

NCT01553851 2016-12-26

GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

Phase 2 Completed

20 enrolled 13 charts

Mouth Neoplasms